Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
As the CEO of a pharmaceutical company facing a critical situation with our best-selling drug, my primary responsibility is to balance patient safety, ethical obligations, legal and regulatory requirements, and the financial health of the company while maintaining transparency and trust with stakeholders.Read the full answer